What is Minimally Adequate Treatment of Psychosis and Should Duration of Inadequate Treatment (DIT) be a Clinical and Research Target?:A Perspective and State-of-the-Art Review

Background and Hypothesis<br/>Persistent symptoms and disability are common in psychotic disorders. This may be partly attributable to inadequate antipsychotic treatment, but there has not been a recent overview of what constitutes inadequate treatment and its impact on outcomes. <br/><br/>Study Design <br/>We focus on the latest meta-analyses to critically appraise the relationship between markers of inadequate antipsychotic treatment and outcomes from the first episode of psychosis onwards, relating outcomes to periods without antipsychotic use, antipsychotic treatment of subtherapeutic dose/duration, and antipsychotic partial/non-adherence. <br/><br/>Study Results<br/>Inadequate antipsychotic treatment is common (non-adherence rates=44-56%), and repeatedly associated with poorer outcomes across several key patient-centred outcomes, including increased risk of relapse (relative risk (RR) up to 2.70, n=13,988), more severe overall symptoms (standardised mean difference (SMD) up to 0.78, n=8,878), poorer quality-of-life (SMD up to 0.50, n=1,421), poorer functioning (SMD up to 0.55, n=1,988) and higher mortality (RR up to 1.83, n=272,030). We also find there is more evidence for schizophrenia than other psychotic disorders. <br/><br/>Conclusions<br/>We identify that there are no operationalised criteria for the minimally adequate treatment of psychosis, in contrast to major depression, for example. We propose that a longer duration of inadequate treatment (DIT) may be an important predictor of outcome, although this has not been tested. To address this and support the development of interventions to reduce inadequate treatment, we propose operationalised criteria for the minimally adequate treatment of psychosis and the DIT, proposing both clinically applicable and research criteria. Finally, we consider future directions for research and practice.<br/>

Authors

Publication Details

Journal
Research Portal (King's College London)
Published
2026-01-26
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What is Minimally Adequate Treatment of Psychosis and Should Duration of Inadequate Treatment (DIT) be a Clinical and Research Target?:A Perspective and State-of-the-Art Review

Martin; id_orcid 0000-0002-5462-8464 Osugo, Oliver Howes
Research Portal (King's College London)
Schizophrenia research and treatment
article

What is Minimally Adequate Treatment of Psychosis and Should Duration of Inadequate Treatment (DIT) be a Clinical and Research Target?:A Perspective and State-of-the-Art Review

Martin; id_orcid 0000-0002-5462-8464 Osugo, Oliver Howes
article en

Abstract

Background and Hypothesis<br/>Persistent symptoms and disability are common in psychotic disorders. This may be partly attributable to inadequate antipsychotic treatment, but there has not been a recent overview of what constitutes inadequate treatment and its impact on outcomes. <br/><br/>Study Design <br/>We focus on the latest meta-analyses to critically appraise the relationship between markers of inadequate antipsychotic treatment and outcomes from the first episode of psychosis onwards, relating outcomes to periods without antipsychotic use, antipsychotic treatment of subtherapeutic dose/duration, and antipsychotic partial/non-adherence. <br/><br/>Study Results<br/>Inadequate antipsychotic treatment is common (non-adherence rates=44-56%), and repeatedly associated with poorer outcomes across several key patient-centred outcomes, including increased risk of relapse (relative risk (RR) up to 2.70, n=13,988), more severe overall symptoms (standardised mean difference (SMD) up to 0.78, n=8,878), poorer quality-of-life (SMD up to 0.50, n=1,421), poorer functioning (SMD up to 0.55, n=1,988) and higher mortality (RR up to 1.83, n=272,030). We also find there is more evidence for schizophrenia than other psychotic disorders. <br/><br/>Conclusions<br/>We identify that there are no operationalised criteria for the minimally adequate treatment of psychosis, in contrast to major depression, for example. We propose that a longer duration of inadequate treatment (DIT) may be an important predictor of outcome, although this has not been tested. To address this and support the development of interventions to reduce inadequate treatment, we propose operationalised criteria for the minimally adequate treatment of psychosis and the DIT, proposing both clinically applicable and research criteria. Finally, we consider future directions for research and practice.<br/>

Research Portal (King's College London)
No poverty
Openalex Percentile: Top 74%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

What is Minimally Adequate Treatment of Psychosis and Should Duration of Inadequate Treatment (DIT) be a Clinical and Research Target?:A Perspective and State-of-the-Art Review — Martin; id_orcid 0000-0002-5462-8464 Osugo, Oliver Howes · Research Portal (King's College London) (2026) | TGRS Research Map | TGRS